Fisetin induced apoptosis of senescent cells by targeting the Pi3k-Akt-Bcl-2/Bcl-xl pathway, reduced vascular remodeling, and alleviated aortic aging in T2DM mice. The gene discussed is BCL2; the disease is type 2 diabetes mellitus.